MUDr. Žáková s.r.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Lyme disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Biocodex1 trial
• Eli Lilly and Company1 trial
• NewAmsterdam Pharma1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

  NCT07219602· Phase 3· NewAmsterdam Pharma· Source

• Recruiting

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

  NCT06451913· Phase 4· Biocodex· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Stroke1 recruiting